Benitec Biopharma Inc Share Price Today: Live Updates & Key Insights

Benitec Biopharma Inc share price today is $11.46, up 0.26%. The stock opened at $11.5 against the previous close of $11.44, with an intraday high of $11.78 and low of $11.44.

Benitec Biopharma Inc Share Price Chart

Benitec Biopharma Inc

us-stock
To Invest in {{usstockname}}
us-stock

Benitec Biopharma Inc Share Price Performance

$11.46 0.0026(0.26%) BNTC at 27 Jul 2026 02:14 PM Biotechnology
Lowest Today 11.44
Highest Today 11.78
Today’s Open 11.5
Prev. Close 11.44
52 Week High 16.76
52 Week Low 9.85
Day’s Range: Low 11.44 High 11.78
52-Week Range: Low 9.85 High 16.76
1 day return -
1 Week return -3.52
1 month return -7.03
3 month return -8.95
6 month return -5.89
1 year return +4.17
3 year return +226.88
5 year return -82.21
10 year return -

Benitec Biopharma Inc Institutional Holdings

Suvretta Capital Management, LLC 33.62

HHG PLC 8.37

Franklin Resources Inc 6.92

Adage Capital Partners Gp LLC 6.17

RA Capital Management, LLC 5.39

Nantahala Capital Management, LLC 4.19

HBM Healthcare Investments AG Ord 3.47

BlackRock Inc 3.45

Vanguard Group Inc 3.42

Simplify Health Care ETF 2.93

Franklin Biotechnology Discv A(acc)USD 2.90

Franklin Biotechnology Discovery A 2.90

Vanguard Capital Management, LLC 2.71

Alyeska Investment Group, L.P. 2.18

SILVERARC CAPITAL MANAGEMENT, LLC 2.09

Balyasny Asset Management LLC 1.90

Millennium Management LLC 1.90

Vanguard Total Stock Mkt Idx Inv 1.89

Simplify Asset Management Inc. 1.64

iShares Russell 2000 ETF 1.56

Geode Capital Management, LLC 1.53

Janus Henderson Hrzn Biotec E2 USD 1.16

Franklin Small Cap Growth Adv 1.04

State Street Corp 0.98

Franklin US Small Cap Growth Equity 0.96

Ameriprise Financial Inc 0.93

Vanguard Institutional Extnd Mkt Idx Tr 0.82

MYDA Advisors LLC 0.65

The Goldman Sachs Group Inc 0.63

MEDICAL BioHealth EUR Acc 0.57

Fidelity Small Cap Index 0.56

Awm Investment Company Inc 0.55

iShares Russell 2000 Value ETF 0.54

Fidelity Extended Market Index 0.38

Russell 2000 Equity Index Fund B 0.36

Russell 2000 Index Non-Lendable Fund 0.36

Vanguard Russell 2000 ETF 0.36

State St Russell Sm Cap® Idx SL Cl I 0.23

iShares Micro-Cap ETF 0.21

Extended Equity Market Fund E 0.20

Benitec Biopharma Inc Market Status

Strong Buy: 4

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Benitec Biopharma Inc Fundamentals

Market Cap 393.01 M

PB Ratio 2.1456

PE Ratio 0.0

Enterprise Value 209.13 M

Total Assets 99.59 M

Volume 161893

Benitec Biopharma Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:216000 0.2M, FY23:75000 0.1M, FY22:73000 0.1M, FY21:59000 0.1M

Annual Profit FY25:-396000 -0.4M, FY24:108000 0.1M, FY23:75000 0.1M, FY22:64000 0.1M, FY21:-64000 -0.1M

Annual Net worth FY25:-37917000 -37.9M, FY24:-21751000 -21.8M, FY23:-19562000 -19.6M, FY22:-18562000 -18.6M, FY21:-13781000 -13.8M

Quarterly Revenue Q1/2026:0 0.0M, Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:556000 0.6M, Q1/2025:0 0.0M

Quarterly Profit Q1/2026:-119000 -0.1M, Q4/2025:-120000 -0.1M, Q3/2025:-118000 -0.1M, Q2/2025:278000 0.3M, Q1/2025:-106000 -0.1M

Quarterly Net worth Q1/2026:-11935000 -11.9M, Q4/2025:-11837000 -11.8M, Q3/2025:-8965000 -9.0M, Q2/2025:-16147000 -16.1M, Q1/2025:-9354000 -9.4M

About Benitec Biopharma Inc & investment objective

Company Information Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Organisation Biotechnology

Employees 19

Industry Biotechnology

CEO Dr. Jerel A. Banks M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Benitec Biopharma Inc FAQs

What is the share price of Benitec Biopharma Inc today?

The current share price of Benitec Biopharma Inc is $11.46.

Can I buy Benitec Biopharma Inc shares in India?

Yes, Indian investors can buy Benitec Biopharma Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Benitec Biopharma Inc shares in India?

You can easily invest in Benitec Biopharma Inc shares from India by:

Can I buy fractional shares of Benitec Biopharma Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Benitec Biopharma Inc?

Benitec Biopharma Inc has a market cap of $393.01 M.

In which sector does Benitec Biopharma Inc belong?

Benitec Biopharma Inc operates in the Biotechnology sector.

What documents are required to invest in Benitec Biopharma Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Benitec Biopharma Inc?

The PE ratio of Benitec Biopharma Inc is N/A and the PB ratio is 2.15.